154 related articles for article (PubMed ID: 17109077)
1. Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry.
Yamashita R; Fujiwara Y; Ikari K; Hamada K; Otomo A; Yasuda K; Noda M; Kaburagi Y
Mol Cell Biochem; 2007 Apr; 298(1-2):83-92. PubMed ID: 17109077
[TBL] [Abstract][Full Text] [Related]
2. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry.
Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS
Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
4. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B.
Slany A; Haudek VJ; Zwickl H; Gundacker NC; Grusch M; Weiss TS; Seir K; Rodgarkia-Dara C; Hellerbrand C; Gerner C
J Proteome Res; 2010 Jan; 9(1):6-21. PubMed ID: 19678649
[TBL] [Abstract][Full Text] [Related]
5. Comparison of alternative extraction methods for secretome profiling in human hepatocellular carcinoma cells.
Cao J; Shen C; Zhang J; Yao J; Shen H; Liu Y; Lu H; Yang P
Sci China Life Sci; 2011 Jan; 54(1):34-8. PubMed ID: 21253868
[TBL] [Abstract][Full Text] [Related]
6. Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines.
Megger DA; Pott LL; Ahrens M; Padden J; Bracht T; Kuhlmann K; Eisenacher M; Meyer HE; Sitek B
Biochim Biophys Acta; 2014 May; 1844(5):967-76. PubMed ID: 23954498
[TBL] [Abstract][Full Text] [Related]
7. Analysis of microdissected cells by two-dimensional LC-MS approaches.
Li C; Yi-Hong ; Tan YX; Ai JH; Zhou H; Li SJ; Zhang L; Xia QC; Wu JR; Wang HY; Zeng R
Methods Mol Biol; 2008; 428():193-208. PubMed ID: 18287775
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of proteins secreted by HepG2 cells treated with butyl benzyl phthalate.
Choi S; Park SY; Kwak D; Phark S; Lee M; Lim JY; Jung WW; Sul D
J Toxicol Environ Health A; 2010; 73(21-22):1570-85. PubMed ID: 20954082
[TBL] [Abstract][Full Text] [Related]
9. Protein identification assisted by the prediction of retention time in liquid chromatography/tandem mass spectrometry.
Wang Y; Zhang J; Gu X; Zhang XM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):122-8. PubMed ID: 16159714
[TBL] [Abstract][Full Text] [Related]
10. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry.
Li C; Hong Y; Tan YX; Zhou H; Ai JH; Li SJ; Zhang L; Xia QC; Wu JR; Wang HY; Zeng R
Mol Cell Proteomics; 2004 Apr; 3(4):399-409. PubMed ID: 14726492
[TBL] [Abstract][Full Text] [Related]
11. Shotgun proteomic analysis of microdissected postmortem human pituitary using complementary two-dimensional liquid chromatography coupled with tandem mass spectrometer.
Liu Y; Zhuang D; Hou R; Li J; Xu G; Song T; Chen L; Yan G; Pang Q; Zhu J
Anal Chim Acta; 2011 Mar; 688(2):183-90. PubMed ID: 21334484
[TBL] [Abstract][Full Text] [Related]
12. Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional culture.
Tit-Oon P; Chokchaichamnankit D; Khongmanee A; Sawangareetrakul P; Svasti J; Srisomsap C
Int J Oncol; 2014 Nov; 45(5):2108-16. PubMed ID: 25189380
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
Gritsenko MA; Xu Z; Liu T; Smith RD
Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
[TBL] [Abstract][Full Text] [Related]
14. iTRAQ-coupled 2D LC-MS/MS analysis of secreted proteome of HBV-replicating HepG2 cells: potential in biomarkers for prognosis of HCC.
Feng H; Wang M; Chen WN
Curr Microbiol; 2010 Oct; 61(4):280-4. PubMed ID: 20165850
[TBL] [Abstract][Full Text] [Related]
15. iTRAQ-coupled 2-D LC-MS/MS analysis of protein profile associated with HBV-modulated DNA methylation.
Niu D; Sui J; Zhang J; Feng H; Chen WN
Proteomics; 2009 Aug; 9(15):3856-68. PubMed ID: 19639599
[TBL] [Abstract][Full Text] [Related]
16. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
17. An off-line high pH reversed-phase fractionation and nano-liquid chromatography-mass spectrometry method for global proteomic profiling of cell lines.
Wang H; Sun S; Zhang Y; Chen S; Liu P; Liu B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():90-5. PubMed ID: 25463202
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.
Mbeunkui F; Metge BJ; Shevde LA; Pannell LK
J Proteome Res; 2007 Aug; 6(8):2993-3002. PubMed ID: 17608509
[TBL] [Abstract][Full Text] [Related]
20. Isotope-labeling and affinity enrichment of phosphopeptides for proteomic analysis using liquid chromatography-tandem mass spectrometry.
Kota U; Chien KY; Goshe MB
Methods Mol Biol; 2009; 564():303-21. PubMed ID: 19544030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
